Navigation Links
TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System

ProductsTAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System
Company Boston Scientific Corporation
Item TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System
Features A Proven Stent
The Express Stent platform offers excellent deliverability and conformability.
  • Excellent deliverability allows for treatment of a variety of patient and lesion types.
  • Excellent conformability allows the stent to mold to the natural contours of the vessel wall.
  • Broad working range facilitates precise deployment and sizing flexibility, making it easy to achieve full stent apposition.
  • A Reliable Polymer
    The TAXUS stent uses Translute Polymer, a proprietary polymer carrier technology, to control drug release.
  • he durable Translute Polymer protects the drug and maintains coating integrity during preparation, delivery, and stent expansion.
  • The polymer controls the release of paclitaxel, which may allow for consistent drug release and more uniform drug distribution.
  • An Effective Drug
    The unique properties of paclitaxel may contribute to the efficacy of the TAXUS Stent.
  • Paclitaxel's multi-functional effects, stabilize microtubules and inhibit activities that contribute to restenosis.
  • Paclitaxel is highly lipophilic, which may contribute to more uniform drug distribution.
  • At the dose used in the TA
  • Description The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3.75 mm in diameter.
    Info Boston Scientific Corporation
    Customer Service: (888) 272-1001
    Web site: http://www.bostonscientific.com

    Related medicine products :

    1. TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
    2. NIR Elite Monorail Stent System
    3. Cutting Balloon Ultra2 Monorail Platform
    4. Atlantis SR Pro Coronary Imaging Catheter
    5. Cypher Sirolimus-eluting Coronary Stent
    6. MULTI-LINK OTW PIXEL Coronary Stent System
    7. MULTI-LINK RX PIXEL Coronary Stent System
    8. Express Coronary Stent System
    9. S660 with Discrete Technology Coronary Stent System
    10. MULTI-LINK OTW ZETA Coronary Stent System
    11. MULTI-LINK OTW PENTA Coronary Stent System
    Bechert-McPherson tying forceps, angled, 10 mm tying platforms....
    Girard curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 99 mm....
    Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
    Straight tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
    Medicine Products:
    (Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
    (Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
    (Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
    (Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
    (Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
    Breaking Medicine News(10 mins):
    (Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
    (Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
    (Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
    Breaking Medicine Technology: